MF59 News
Most Popular MF59 Story
Novartis: Data supports pre-pandemic vaccinations
Novartis is touting new data showing that a single jab of one of its vaccines induced a protective antibody response in patients who had already been vaccinated as much as six years earlier. The... Read more...
Latest Headlines
- September 19, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
